Marie-José Blivet-Van Eggelpoël

Insulin and IGF-1 stimulate the β-catenin pathway through two signalling cascades involving GSK-3β inhibition and Ras activation

Christèle Desbois‐Mouthon, Axelle Cadoret, Marie-José Blivet-Van Eggelpoël et al. · Oncogene · 2001 · 321 citations

Life Sciences, Cell Biology, Molecular Biology +13

Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells

Marie-José Blivet-Van Eggelpoël, Hamza Chettouh, Lynda Aoudjehane et al. · Journal of Hepatology · 2012 · 177 citations

Medicine, Cell Biology, Oncology +16

Insulin-Like Growth Factor-1 Receptor Inhibition Induces a Resistance Mechanism via the Epidermal Growth Factor Receptor/HER3/AKT Signaling Pathway: Rational Basis for Cotargeting Insulin-Like Growth Factor-1 Receptor and Epidermal Growth Factor Receptor in Hepatocellular Carcinoma

Christèle Desbois‐Mouthon, Aurore Baron, Marie-José Blivet-Van Eggelpoël et al. · Clinical Cancer Research · 2009 · 153 citations

Medicine, Oncology, Pharmacology +17

Impact of IGF‐1R/EGFR cross‐talks on hepatoma cell sensitivity to gefitinib

Christèle Desbois‐Mouthon, Wulfran Cacheux, Marie-José Blivet-Van Eggelpoël et al. · International Journal of Cancer · 2006 · 111 citations · Full text

Medicine, Oncology, Pharmacology +17

GSK-3β inhibition by lithium confers resistance to chemotherapy-induced apoptosis through the repression of CD95 (Fas/APO-1) expression

Eléonore Beurel, Michel Kornprobst, Marie-José Blivet-Van Eggelpoël et al. · Experimental Cell Research · 2004 · 72 citations

Life Sciences, Cell Biology, Oncology +16